Zomedica Corp. (ZOM) stock plunged -8.56% to 0.1859 in the After-hours on Friday

However, the company announced mid-last-week that while the special virtual-only meeting of shareholders where a majority voted in favor of the company’s domestication to Delaware, shareholders failed to complete a 2/3 vote in favor of it, and the localization will therefore not happen.

Covered by approximately 70 granted and pending patents, the TRUFORMA diagnostic platform uses Qorvo’s (NASDAQ: QRVO) developed Bulk Acoustic Wave technology to provide a non-optical and fluorescence-free point-of-care detection method. This technology is widely used in the most advanced radar and communication systems globally and has proven extremely reliable and precise. Sales of TRUFORMA are expected to begin on March 30, 2021, according to Zomedica.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Read More

Most Popular

Related posts